A
Andrea Rubboli
Researcher at Loyola University Medical Center
Publications - 133
Citations - 2815
Andrea Rubboli is an academic researcher from Loyola University Medical Center. The author has contributed to research in topics: Percutaneous coronary intervention & Atrial fibrillation. The author has an hindex of 23, co-authored 111 publications receiving 2454 citations.
Papers
More filters
Journal ArticleDOI
Use of bempedoic acid for LDL cholesterol lowering and cardiovascular risk reduction: a consensus document from the Italian study group on atherosclerosis, thrombosis and vascular biology.
Giuseppe Patti,Ilaria Cavallari,Arturo Cesaro,Felice Gragnano,Letizia Riva,Fabio Fimiani,Claudio Cuccia,Claudio Fresco,Paolo Calabrò,Sergio Leonardi,Rossella Marcucci,Andrea Rubboli +11 more
TL;DR: The benefits of LDL cholesterol lowering for cardiovascular disease prevention is well documented as mentioned in this paper , and an updated therapeutic algorithm for pharmacological LDL-C lowering in view of the introduction of bempedoic acid in clinical practice.
Journal ArticleDOI
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.
D. Gorog,José Luis Ferreiro,Ingo Ahrens,Junya Ako,Tobias Geisler,Sigrun Halvorsen,K. Huber,Young-Hoon Jeong,Eliano Pio Navarese,Andrea Rubboli,Dirk Sibbing,Jolanta M. Siller-Matula,Robert F. Storey,Jurriën M. ten Berg,Marco Valgimigli,Christophe Vandenbriele,Gregory Y.H. Lip +16 more
Journal ArticleDOI
[Diagnosis and therapy of pulmonary arterial hypertension in Italy: results of the INCIPIT2 survey].
Iolanda Enea,Loris Roncon,Michele Azzarito,Amedeo Bongarzoni,Franco Casazza,Carlo D'Agostino,Giuseppe Favretto,Andrea Rubboli,Pietro Zonzin +8 more
TL;DR: The results show the interest of Italian Cardiology to find a pathway for the diagnosis of PAH and a heterogeneity suggesting the need for a shareable pathway, thus improving the collaboration between peripheral cardiology departments and the excellence centers for PAH in a functional Hub & Spoke network.